Načítá se...
Specific targeting of the deubiquitinase and E3 ligase families with engineered ubiquitin variants
The ubiquitin proteasome system (UPS) has garnered much attention due to its potential for the development of therapeutics. Following a successful clinical application of general proteasome inhibitors much effort has been devoted to targeting individual UPS components including E3 enzymes and deubiq...
Uloženo v:
| Vydáno v: | Bioeng Transl Med |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley and Sons Inc.
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5434665/ https://ncbi.nlm.nih.gov/pubmed/28580429 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/btm2.10044 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|